Seaport Therapeutics vs Supernus Pharmaceuticals

Seaport Therapeutics vs Supernus Pharmaceuticals, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Seaport Therapeutics is on 62/100 and Supernus Pharmaceuticals on 60/100.

Seaport Therapeutics logo
Seaport TherapeuticsDeveloping novel therapeutics to restore gut lymphatic function.
Try Seaport Therapeutics
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsBiopharmaceutical company developing and commercializing CNS disease treatments.
Try Supernus Pharmaceuticals

Where each one leads

Seaport Therapeutics

  • funding raised: $340M against $17.5M

Supernus Pharmaceuticals

  • domain rating: 67/100 against 32/100
  • headcount: 809 against 64

At a glance

MeasureSeaport TherapeuticsSupernus Pharmaceuticals
What it isDeveloping novel therapeutics to restore gut lymphatic function.Biopharmaceutical company developing and commercializing CNS disease treatments.
CategoryBiotechnology, Pharmaceuticals, HealthTechBiotechnology, Pharmaceuticals, Healthcare, Neuroscience
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20212005
HeadquartersCambridge, USARockville, United States
StatusActiveActive

Size, funding and growth

MeasureSeaport TherapeuticsSupernus Pharmaceuticals
Employees64809
Total funding$340M$17.5M
Latest roundUnknownSeries A
Valuation$1.1BNot published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureSeaport TherapeuticsSupernus Pharmaceuticals
StartupHub scoreOur 0-100 rating62/10060/100
Traction58/10056/100
Team70/10030/100
Search visibility9/10015/100
Quality78/10078/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (41/100)
Domain ratingLink authority, 0-10032/10067/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureSeaport TherapeuticsSupernus Pharmaceuticals
HostingNot detectedAWS
CDNCloudflareNot detected
CMSWordPressNot detected
FrameworksJquery, BootstrapTailwind CSS, Bootstrap
AnalyticsGoogle Analytics 4Google Tag Manager

Seaport Therapeutics vs Supernus Pharmaceuticals: common questions

Which is better, Seaport Therapeutics or Supernus Pharmaceuticals?

On our 0-100 score Seaport Therapeutics rates higher (62/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Seaport Therapeutics and Supernus Pharmaceuticals compare on the numbers?

Seaport Therapeutics leads on funding raised ($340M against $17.5M). Supernus Pharmaceuticals leads on domain rating (67/100 against 32/100), headcount (809 against 64).

Read the full Seaport Therapeutics review and pricing or the Supernus Pharmaceuticals review and pricing. You can also browse other Seaport Therapeutics alternatives we track.